Clinical Trials on Metastatic Breast Cancer (MBC)
Total 16168 results
-
Hamdy A. AzimRecruitingPalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (FATIMA)Metastatic Breast CancerSouth Africa
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
PfizerAstraZenecaCompletedMetastatic Breast CancerKorea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
MedSIRGlaxoSmithKlineCompletedBreast Cancer | Breast Cancer MetastaticSpain
-
Sidney Kimmel Comprehensive Cancer Center at Johns...PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
Institut CurieTerminated
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Dana-Farber Cancer InstituteActive, not recruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Translational Drug DevelopmentSide-Out FoundationCompletedMetastatic Breast CancerUnited States
-
UNICANCERPfizerActive, not recruitingMetastatic Breast CancerFrance
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
PfizerActive, not recruiting
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
Turkish Oncology GroupIstanbul University; Marmara University Pendik Training and Research Hospital; V.K.V. American Hospital, Istanbul and other collaboratorsCompletedMetastatic Breast CancerTurkey
-
Fudan UniversityActive, not recruitingMetastatic Breast CancerChina
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
University of VirginiaSyndax PharmaceuticalsCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
Sun Yat-sen UniversityCompletedBreast Cancer MetastaticChina
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Hager salah el dinCompletedMetastatic Breast CancerEgypt
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCTerminated
-
Ozmosis Research Inc.Breast Cancer Research FoundationCompletedMetastatic Breast CancerCanada
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Eisai LimitedCompletedMetastatic Breast CancerUnited Kingdom, Bulgaria, Russian Federation
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
University of Texas Southwestern Medical CenterWithdrawn
-
Baylor Breast Care CenterPfizerTerminatedMetastatic Breast CancerUnited States
-
Side-Out FoundationTranslational Drug DevelopmentCompleted
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
-
NewLink Genetics CorporationCompletedMetastatic Breast CancerUnited States, Poland
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
University of Wisconsin, MadisonSanofiCompleted
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
CelgeneCompletedMetastatic Breast CancerUnited States